The Role of Oral Beclometasone Dipropionate in the Treatment of Gastrointestinal Graft-versus-Host Disease

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Drugs

• Publication date

  2009-07-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.2165/00003495-200969100-00004PMID 19583452
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beclomethasone Dipropionate Inhaler: A Review of its Pharmacology, Therapeutic Value and Adverse Effects

  2012cited by this paper
• Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD

  2009cited by this paper
• Promising progression-free survival for patients low and intermediate grade lymphoid malignancies after nonmyeloablative umbilical cord blood transplantation.

  2009cited by this paper
• Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism.

  2009cited by this paper
• Nonabsorbable corticosteroids use in the treatment of gastrointestinal graft-versus-host disease.

  2009cited by this paper
• Lung function and asthma control with beclomethasone and formoterol in a single inhaler.

  2009cited by this paper
• Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

  2008cited by this paper
• Beclometasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease

  2008cited by this paper
• Relative oral corticosteroid-sparing effect of 7 inhaled corticosteroids in chronic asthma: a meta-analysis.

  2008cited by this paper
• Enteral budesonide in treatment for mild and moderate gastrointestinal chronic GVHD

  2008cited by this paper
• Evolution of Mammals and Their Gut Microbes

  2008cited by this paper
• A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.

  2007cited by this paper
• Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease.

  2007cited by this paper
• Oral beclomethasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease following allogeneic hematopoietic cell transplantation

  2007cited by this paper
• Treatment of acute graft-versus-host disease with prednisolone: significant survival advantage for day +5 responders and no advantage for nonresponders receiving anti-thymocyte globulin.

  2006cited by this paper
• Potencies of topical glucocorticoids to mediate genomic and nongenomic effects on human peripheral blood mononuclear cells.

  2006cited by this paper
• Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD).

  2006cited by this paper
• Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease.

  2005cited by this paper
• Immunotherapy and chemotherapy — a practical partnership

  2005cited by this paper
• Topical Treatment of Distal Active Ulcerative Colitis With Beclomethasone Dipropionate or Mesalamine: A Single-blind Randomized Controlled Trial

  2005cited by this paper
• Treatment of steroid-resistant acute graft-versus-host disease with daclizumab and etanercept

  2005cited by this paper
• Effect of up-front daclizumab when combined with steroids for the treatment of acute graft-versus-host disease: results of a randomized trial.

  2004cited by this paper
• Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors.

  2004cited by this paper
• Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome.

  2004cited by this paper
• Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.

  2004cited by this paper
• Molecules and mechanisms of the graft-versus-leukaemia effect

  2004cited by this paper
• Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants.

  2004cited by this paper
• Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction

  2003cited by this paper
• Erratum: Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction (Nature Immunology (2003) vol. 4 (154-160))

  2003cited by this paper
• Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy.

  2003cited by this paper
• Prevention of graft-versus-host disease while preserving graft-versus-leukemia effect after selective depletion of host-reactive T cells by photodynamic cell purging process.

  2002cited by this paper
• Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival.

  2002cited by this paper
• The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease.

  2002cited by this paper
• Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double‐blind placebo‐controlled study

  2002cited by this paper
• Endothelial Apoptosis as the Primary Lesion Initiating Intestinal Radiation Damage in Mice

  2001cited by this paper
• Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis.

  2001cited by this paper
• Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man.

  2001cited by this paper
• The history and future of T-cell depletion as graft-versus-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation.

  2001cited by this paper
• The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation.

  2000cited by this paper
• A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease.

  2000cited by this paper
• Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation.

  1999cited by this paper
• Feasibility and response to budesonide as topical corticosteroid therapy for acute intestinal GVHD

  1999cited by this paper
• Inhaled beclomethasone versus placebo for chronic asthma.

  1999cited by this paper
• CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells.

  1999cited by this paper
• Oral beclomethasone dipropionate for treatment of intestinal graft-versus-host disease: a randomized, controlled trial.

  1998cited by this paper
• Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients.

  1998cited by this paper
• Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation.

  1998cited by this paper
• Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation.

  1998cited by this paper
• Gastric graft-versus-host disease: a blinded histologic study.

  1997cited by this paper
• Oral budesonide is as effective as oral prednisolone in active Crohn’s disease

  1997cited by this paper
• Treatment of active and postactive ileal and colonic Crohn's disease with oral pH-modified-release budesonide. German Budesonide Study Group.

  1997cited by this paper
• Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.

  1996cited by this paper
• Evaluation of a CD5-specific immunotoxin for treatment of acute graft- versus-host disease after allogeneic marrow transplantation

  1996cited by this paper
• Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.

  1996cited by this paper
• Oral pH-modified release budesonide versus 6-methylprednisolone in active Crohn's disease. German/Austrian Budesonide Study Group.

  1996cited by this paper
• Oral budesonide as maintenance treatment for Crohn's disease: a placebo-controlled, dose-ranging study. Canadian Inflammatory Bowel Disease Study Group.

  1996cited by this paper
• Treatment of acute graft-versus-host disease with methylprednisolone and cyclosporine with or without an anti-interleukin-2 receptor monoclonal antibody. A multicenter phase III study.

  1995cited by this paper
• TREATMENT OF ACUTE GRAFT‐VERSUS-HOST DISEASE WITH METHYLPREDNISOLONE AND CYCLOSPORINE WITH OR WITHOUT AN ANTI‐INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY: A Multicenter Phase III Study

  1995cited by this paper
• ORAL BECLOMETHASONE DIPROPIONATE FOR TREATMENT OF HUMAN INTESTINAL GRAFT‐VERSUS-HOST DISEASE

  1995cited by this paper
• A prospective randomized trial

  1995cited by this paper
• A comparison of budesonide with prednisolone for active Crohn's disease.

  1994cited by this paper
• Etiology and outcome of diarrhea after marrow transplantation: a prospective study.

  1994cited by this paper
• PREDNISONE THERAPY FOR ACUTE GRAFT‐VERSUS-HOST DISEASE: SHORT‐VERSUS LONG‐TERM TREATMENT

  1993cited by this paper
• Double blind trial of oral fluticasone propionate v prednisolone in the treatment of active ulcerative colitis.

  1993cited by this paper
• Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults.

  1992cited by this paper
• Histologic similarity of murine colonic graft-versus-host disease (GVHD) to human colonic GVHD and inflammatory bowel disease.

  1990cited by this paper
• A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment.

  1990cited by this paper
• Graft-versus-leukemia reactions after bone marrow transplantation.

  1990cited by this paper
• A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment.

  1990cited by this paper
• Activation of beclomethasone dipropionate by hydrolysis to beclomethasone‐17‐monopropionate

  1990cited by this paper
• Treatment of distal ulcerative colitis with beclomethasone enemas: High therapeutic efficacy without endocrine side effects

  1987cited by this paper
• Coating of oral beclomethasone dipropionate capsules with cellulose acetate phthalate enhances delivery of topically active antiinflammatory drug to the terminal ileum.

  1987cited by this paper
• Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation.

  1986cited by this paper
• Bone marrow transplantation in patients aged 45 years and older.

  1986cited by this paper
• Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts

  1985cited by this paper
• Effects of in vitro depletion of T cells in HLA-identical allogeneic marrow grafts.

  1985cited by this paper
• Treatment of acute graft-versus-host disease after allogeneic marrow transplantation. Randomized study comparing corticosteroids and cyclosporine.

  1985cited by this paper
• Treatment of human acute graft-versus-host disease with antithymocyte globulin and cyclosporine with or without methylprednisolone.

  1985cited by this paper
• Marrow transplantation from related donors other than HLA-identical siblings.

  1985cited by this paper
• Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.

  1983cited by this paper
• Graft-versus-host disease of the intestine: a protein losing enteropathy characterized by fecal alpha 1-antitrypsin.

  1983cited by this paper
• Graft-Versus-Host Disease of the Intestine: A Protein Losing Enteropathy Characterized by Fecal α1-Antitrypsin

  1983cited by this paper
• Treatment of graft‐versus‐host disease in human allogeneic marrow graft recipients: A randomized trial comparing antithymocyte globulin and corticosteroids

  1981cited by this paper
• Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts.

  1979cited by this paper
• Absorption and metabolism of orally administered beclomethasone dipropionate

  1974cited by this paper
• Absorption and metabolism of orally administered beclomethsone dipropionate.

  1974cited by this paper
• The biology of graft-versus-host reactions.

  1966cited by this paper
• The biology of graft-versus-host reactions.

  1966cited by this paper

• Graft-versus-host disease in oncology nursing practice.

  2014cites this paper